The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR

BMC Molecular Biology

Volumn 11, Issue , 2010, Pages

  Guyot, Romain ^a   Vincent, Séverine ^a   Bertin, Julie ^a   Samarut, Jacques ^a,b   Ravel Chapuis, Patrick ^a  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLUTATHIONE TRANSFERASE; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR; TRANSFORMING ACIDIC COILED COIL 1 PROTEIN; UNCLASSIFIED DRUG; FETOPROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NUCLEAR PROTEIN; RETINOIC ACID RECEPTOR ALPHA; TACC1 PROTEIN, HUMAN; THYROID HORMONE RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CELL STRAIN COS7; CELL STRAIN HEK293; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR OCCUPANCY; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM; ANIMAL; CELL LINE; METABOLISM; MOUSE; MUTATION; PROTEIN BINDING;

ANIMALS; CELL LINE; CELL NUCLEUS; FETAL PROTEINS; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; NUCLEAR PROTEINS; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; THYROID HORMONE RECEPTORS ALPHA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 76949084443     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-11-3     Document Type: Article

References (47)

1. Jepsen K, Rosenfeld MG. Biological roles and mechanistic actions of co-repressor complexes. Journal of cell science 2002, 115(Pt 4):689-698.
2. Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes & development 2006, 20(11):1405-1428.
3. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocrine reviews 2007, 28(5):575-587. 10.1210/er.2007-0012, 17609497.
4. Lonard DM, O'Malley BW. Expanding functional diversity of the coactivators. Trends in biochemical sciences 2005, 30(3):126-132. 10.1016/j.tibs.2005.01.001, 15752984.
5. Still IH, Vettaikkorumakankauv AK, DiMatteo A, Liang P. Structure-function evolution of the transforming acidic coiled coil genes revealed by analysis of phylogenetically diverse organisms. BMC Evol Biol 2004, 4(16). 441373, 15207008.
6. Stewart JP, Thompson A, Santra M, Barlogie B, Lappin TR, Shaughnessy J. Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma. British journal of haematology 2004, 126(1):72-76. 10.1111/j.1365-2141.2004.04996.x, 15198734.
7. Still IH, Hamilton M, Vince P, Wolfman A, Cowell JK. Cloning of TACC1, an embryonicallyexpressed potentially transforming coiled coil containing gene from the 8p11 breast cancer amplicon. Oncogene 1999, 18(27):4032-4038. 10.1038/sj.onc.1202801, 10435627.
8. Still IH, Vince P, Cowell JK. The third member of the transforming acidic coiled coil-containing gene family TACC3, maps in 4p16, close to translocation breakpoints in multiplemyeloma and is upregulated in various cancer cell lines. Genomics 1999, 58(2):165-170. 10.1006/geno.1999.5829, 10366448.
9. Conte N, Charafe-Jauffret E, Delaval B, Adelaide J, Ginestier C, Geneix J, Isnardon D, Jacquemier J, Birnbaum D. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators. Oncogene 2002, 21(36):5619-5630. 10.1038/sj.onc.1205658, 12165861.
10. Conte N, Delaval B, Ginestier C, Ferrand A, Isnardon D, Larroque C, Prigent C, Seraphin B, Jacquemier J, Birnbaum D. TACC1-chTOG-Aurora A protein complex in breast cancer. Oncogene 2003, 22(50):8102-8116. 10.1038/sj.onc.1206972, 14603251.
11. Devilard E, Bladou F, Ramuz O, Karsenty G, Dales JP, Gravis G, Nguyen C, Bertucci F, Xerri L, Birnbaum D. FGFR1 and WT1 are markers of human prostate cancer progression. BMC Cancer 2006, 6:272. 10.1186/1471-2407-6-272, 1698935, 17137506.
12. Lauffart B, Vaughan MM, Eddy R, Chervinsky D, DiCioccio RA, Black JD, Still IH. Aberrations of TACC1 and TACC3 are associated with ovarian cancer. BMC Womens Health 2005, 5:8. 10.1186/1472-6874-5-8, 1175095, 15918899.
13. Line A, Slucka Z, Stengrevics A, Silina K, Li G, Rees RC. Characterisation of tumour-associated antigens in colon cancer. Cancer Immunol Immunother 2002, 51(10):574-582. 10.1007/s00262-002-0322-2, 12384809.
14. Line A, Stengrevics A, Slucka Z, Li G, Jankevics E, Rees RC. Serological identification and expression analysis of gastric cancer-associated genes. British journal of cancer 2002, 86(11):1824-1830. 10.1038/sj.bjc.6600321, 2375403, 12087473.
15. Partheen K, Levan K, Osterberg L, Horvath G. Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. Eur J Cancer 2006, 42(16):2846-2854. 10.1016/j.ejca.2006.06.026, 16996261.
16. Gergely F. Centrosomal TACCtics. Bioessays 2002, 24(10):915-925. 10.1002/bies.10162, 12325124.
17. Theurkauf WE. TACCing down the spindle poles. Nature cell biology 2001, 3(7):E159-161. 10.1038/35083110, 11433309.
18. Peset I, Vernos I. The TACC proteins: TACC-ling microtubule dynamics and centrosome function. Trends in cell biology 2008, 18(8):379-388. 10.1016/j.tcb.2008.06.005, 18656360.
19. Raff JW. Centrosomes and cancer: lessons from a TACC. Trends in cell biology 2002, 12(5):222-225. 10.1016/S0962-8924(02)02268-7, 12062169.
20. Stebbins-Boaz B, Cao Q, de Moor CH, Mendez R, Richter JD. Maskin is a CPEB-associated factor that transiently interacts with elF-4E. Molecular cell 1999, 4(6):1017-1027. 10.1016/S1097-2765(00)80230-0, 10635326.
21. Sadek CM, Jalaguier S, Feeney EP, Aitola M, Damdimopoulos AE, Pelto-Huikko M, Gustafsson JA. Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development. Mechanisms of development 2000, 97(1-2):13-26. 10.1016/S0925-4773(00)00415-9, 11025203.
22. Gangisetty O, Lauffart B, Sondarva GV, Chelsea DM, Still IH. The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. Oncogene 2004, 23(14):2559-2563. 10.1038/sj.onc.1207424, 14767476.
23. Lauffart B, Gangisetty O, Still IH. Molecular cloning genomic structure and interactions of the putative breast tumor suppressor TACC2. Genomics 2003, 81(2):192-201. 10.1016/S0888-7543(02)00039-3, 12620397.
24. Lauffart B, Howell SJ, Tasch JE, Cowell JK, Still IH. Interaction of the transforming acidic coiled-coil 1 (TACC1) protein with ch-TOG and GAS41/NuBI1 suggests multiple TACC1-containing protein complexes in human cells. Biochem J 2002, 363(Pt 1):195-200. 10.1042/0264-6021:3630195, 1222467, 11903063.
25. Vettaikkorumakankauv AKLB, Gangisetty O, Cincotta MA, Hawthorne LA, Cowell JK, Still IH. The TACC proteins are coregulators of the rentinoid × Receptor β. Cancer Therapy 2008, 6:805-816.
26. Garriga-Canut M, Orkin SH. Transforming acidic coiled-coil protein 3 (TACC3) controls friend of GATA-1 (FOG-1) subcellular localization and regulates the association between GATA-1 and FOG-1 during hematopoiesis. The Journal of biological chemistry 2004, 279(22):23597-23605. 10.1074/jbc.M313987200, 15037632.
27. Angrisano T, Lembo F, Pero R, Natale F, Fusco A, Avvedimento VE, Bruni CB, Chiariotti L. TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters. Nucleic acids research 2006, 34(1):364-372. 10.1093/nar/gkj400, 1331987, 16410616.
28. Tagami T, Kopp P, Johnson W, Arseven OK, Jameson JL. The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors. Endocrinology 1998, 139(5):2535-2544. 10.1210/en.139.5.2535, 9564869.
29. Selmi-Ruby S, Casanova J, Malhotra S, Roussett B, Raaka BM, Samuels HH. Role of the conserved C-terminal region of thyroid hormone receptor-alpha in ligand-dependent transcriptional activation. Molecular and cellular endocrinology 1998, 138(1-2):105-114. 10.1016/S0303-7207(98)00016-1, 9685219.
30. Line A, Slucka Z, Stengrevics A, Li G, Rees RC. Altered splicing pattern of TACC1 mRNA in gastric cancer. Cancer genetics and cytogenetics 2002, 139(1):78-83. 10.1016/S0165-4608(02)00607-6, 12547166.
31. Lauffart B, Dimatteo A, Vaughan MM, Cincotta MA, Black JD, Still IH. Temporal and spatial expression of TACC1 in the mouse and human. Dev Dyn 2006, 235(6):1638-1647. 10.1002/dvdy.20724, 16496324.
32. Vasios G, Mader S, Gold JD, Leid M, Lutz Y, Gaub MP, Chambon P, Gudas L. The late retinoic acid induction of laminin B1 gene transcription involves RAR binding to the responsive element. The EMBO journal 1991, 10(5):1149-1158. 452768, 1850696.
33. de The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 1990, 343(6254):177-180. 10.1038/343177a0, 2153268.
34. Langston AW, Gudas LJ. Identification of a retinoic acid responsive enhancer 3' of the murine homeobox gene Hox-1.6. Mechanisms of development 1992, 38(3):217-227. 10.1016/0925-4773(92)90055-O, 1360810.
35. Gergely F, Draviam VM, Raff JW. The ch-TOG/XMAP215 protein is essential for spindle pole organization in human somatic cells. Genes & development 2003, 17(3):336-341.
36. Anafi M, Yang YF, Barlev NA, Govindan MV, Berger SL, Butt TR, Walfish PG. GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. Molecular endocrinology (Baltimore, Md) 2000, 14(5):718-732. 10.1210/me.14.5.718, 10809234.
37. Robyr D, Wolffe AP, Wahli W. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Molecular endocrinology (Baltimore, Md) 2000, 14(3):329-347. 10.1210/me.14.3.329, 10707952.
38. Huang SM, Stallcup MR. Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors. Molecular and cellular biology 2000, 20(5):1855-1867. 10.1128/MCB.20.5.1855-1867.2000, 85366, 10669760.
39. Heldring N, Pawson T, McDonnell D, Treuter E, Gustafsson JA, Pike AC. Structural insights into corepressor recognition by antagonist-bound estrogen receptors. The Journal of biological chemistry 2007, 282(14):10449-10455. 10.1074/jbc.M611424200, 17283072.
40. Meng X, Webb P, Yang YF, Shuen M, Yousef AF, Baxter JD, Mymryk JS, Walfish PG. E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(18):6267-6272. 10.1073/pnas.0501491102, 1088377, 15849266.
41. Lauffart B, Sondarva GV, Gangisetty O, Cincotta M, Still IH. Interaction of TACC proteins with the FHL family: implications for ERK signaling. Journal of cell communication and signaling 2007, 1(1):5-15. 10.1007/s12079-007-0001-3, 2267652, 18481206.
42. Vartiainen MK, Guettler S, Larijani B, Treisman R. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science (New York NY) 2007, 316(5832):1749-1752.
43. Cully M, Shiu J, Piekorz RP, Muller WJ, Done SJ, Mak TW. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis. Cancer research 2005, 65(22):10363-10370. 10.1158/0008-5472.CAN-05-1633, 16288026.
44. Chen HM, Schmeichel KL, Mian IS, Lelievre S, Petersen OW, Bissell MJ. AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression. Mol Biol Cell 2000, 11(4):1357-1367. 14852, 10749935.
45. Ghayad SE, Vendrell JA, Bieche I, Spyratos F, Dumontet C, Treilleux I, Lidereau R, Cohen PA. Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer. Journal of molecular endocrinology 2009, 42(2):87-103. 10.1677/JME-08-0076, 18984771.
46. Bonamy GM, Allison LA. Oncogenic conversion of the thyroid hormone receptor by altered nuclear transport. Nuclear receptor signaling 2006, 4(e008). 1472669, 16741566.
47. Gergely F, Karlsson C, Still I, Cowell J, Kilmartin J, Raff JW. The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. Proc Natl Acad Sci USA 2000, 97(26):14352-14357. 10.1073/pnas.97.26.14352, 18922, 11121038.